Genolution Financials
| 225220 Stock | KRW 2,180 80.00 3.54% |
Genolution |
Understanding current and past Genolution Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Genolution's financial statements are interrelated, with each one affecting the others. For example, an increase in Genolution's assets may result in an increase in income on the income statement.
Please note, the presentation of Genolution's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Genolution's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Genolution's management manipulating its earnings.
Genolution Stock Summary
Genolution competes with KNOTUS CoLtd, Bridge Biotherapeutics, AptaBio Therapeutics, Cytogen, and Genolution. Genolution Inc. manufactures and sells IVD products in South Korea and internationally. The company was founded in 2006 and is based in Seoul, South Korea. GENOLUTION is traded on Korean Securities Dealers Automated Quotations in South Korea.| Instrument | Korea Stock View All |
| Exchange | KOSDAQ |
| ISIN | KR7225220003 |
| Business Address | Building A, Seoul, |
| Industry | Biotechnology & Medical Research |
| Benchmark | Dow Jones Industrial |
| Website | www.genolution1.com |
| Phone | 82 2 449 8670 |
| Currency | KRW - South Korean Won |
You should never invest in Genolution without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Genolution Stock, because this is throwing your money away. Analyzing the key information contained in Genolution's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Genolution Key Financial Ratios
Genolution's financial ratios allow both analysts and investors to convert raw data from Genolution's financial statements into concise, actionable information that can be used to evaluate the performance of Genolution over time and compare it to other companies across industries.| Return On Equity | 27.23 | |||
| Beta | -0.23 |
Genolution Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Genolution's current stock value. Our valuation model uses many indicators to compare Genolution value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Genolution competition to find correlations between indicators driving Genolution's intrinsic value. More Info.Genolution is rated second in return on equity category among its peers. It also is rated second in profit margin category among its peers fabricating about 0.02 of Profit Margin per Return On Equity. The ratio of Return On Equity to Profit Margin for Genolution is roughly 62.77 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Genolution by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Genolution's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Genolution Systematic Risk
Genolution's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Genolution volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Genolution correlated with the market. If Beta is less than 0 Genolution generally moves in the opposite direction as compared to the market. If Genolution Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Genolution is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Genolution is generally in the same direction as the market. If Beta > 1 Genolution moves generally in the same direction as, but more than the movement of the benchmark.
Genolution December 23, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Genolution help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Genolution. We use our internally-developed statistical techniques to arrive at the intrinsic value of Genolution based on widely used predictive technical indicators. In general, we focus on analyzing Genolution Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Genolution's daily price indicators and compare them against related drivers.
| Information Ratio | (0.23) | |||
| Maximum Drawdown | 9.9 | |||
| Value At Risk | (4.48) | |||
| Potential Upside | 3.7 |
Complementary Tools for Genolution Stock analysis
When running Genolution's price analysis, check to measure Genolution's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genolution is operating at the current time. Most of Genolution's value examination focuses on studying past and present price action to predict the probability of Genolution's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genolution's price. Additionally, you may evaluate how the addition of Genolution to your portfolios can decrease your overall portfolio volatility.
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Stocks Directory Find actively traded stocks across global markets | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |